The IRB staff will work remotely until campus formally reopens, and you might experience a slight delay in email or phone responses. We will do our best to ensure that disruptions to normal review processes remain minimal.
RESEARCHERS: Given the current concerns about Coronavirus, if you are currently collecting data through in-person interactions with any participants, you should consider restricting your activities. For individual or small-group data collection activities, please be cautious for yourself and others. Your presence and/or the research activities should not increase risk to any individuals with regard to the virus. Follow the guidelines of our University and the recommendations from King County Public Health.
If you need to modify any aspect of your protocol due to the Coronavirus impacts, call or email us, and we will work quickly and closely with you. Apart from ceasing or pausing data collection, do not make any changes to your protocol without prior IRB written approval.
Please contact us with any questions at email@example.com or 206-296-2585.
Contact us with your questions and/or materials! Although our preliminary input will not reflect a formal review, we're happy to talk with you and assist with your project at any stage of development. For more information or to schedule a consultation, please call 206-296-2585 or email firstname.lastname@example.org.
As a Seattle University researcher, you must submit any project proposal involving human subjects as participants to the SU Institutional Review Board (IRB) to comply with SU policy and Federal regulations. The IRB will review the project to assess physical, psychological, legal, and/or social risks to research participants. Through this review process, the IRB will help you minimize risks for participants by establishing protections reflecting best practices in human subjects research and University policies. The IRB also seeks to protect researchers and the University through appropriate design of research studies to comply with Federal regulations and SU requirements.